MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients
- 25 September 2014
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 54 (11), 1442-1450
- https://doi.org/10.1002/mc.22218
Abstract
Expression of miR-96-5p is frequently altered in various types of cancer and the KRAS oncogene has been identified as one of its potential targets. However, the biological role of miR-96-5p expression in colorectal cancer (CRC) and its ability to predict the clinical course of patients have not been investigated yet. In this study, we explored miR-96-5p expression in 80 CRC patients and evaluated the impact on clinical outcome by Kaplan-Meier curves and multivariate Cox proportional models. In vitro miR-96-5p inhibition and overexpression were performed in CRC cells and the effects on cellular growth, anchorage-independent growth, apoptosis, and epithelial-mesenchymal transition (EMT)-related gene expression were explored. Low miR-96-5p expression levels in tumor tissue were associated with distant metastasis (P = 0.025) and multivariate Cox regression analysis identified low levels of miR-96-5p as an independent prognostic factor with respect to cancer-specific survival (hazard ratio = 1.78, 95%CI = 1.03-3.03, P < 0.038). In vitro overexpression of miR-96-5p led to a reduced cellular growth rate (P < 0.05), reduced colonies in soft agar (P < 0.05), corroborated by a decreased cyclin D1 and increased p27-CDKN1A expression (P < 0.05). Forced expression of miR-96-5p in CRC cells entailed no effects on apoptosis or EMT-related genes but decreased the expression levels of the KRAS oncogene (P < 0.05). Despite regulating KRAS expression, there was no significant association in miR-96-5p expression levels and response rates to EGFR-targeting agents. In conclusion, our data suggest that miR-96-5p influences cellular growth of CRC cells and low expression of miR-96-5p seems to be associated with poor clinical outcome in CRC patients.Keywords
Funding Information
- Erwin Schroedinger Scholarship of the Austrian Science Funds (J3389-B23)
This publication has 29 references indexed in Scilit:
- Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer CellsGastroenterology, 2012
- EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersNature Medicine, 2011
- Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal CancerClinical Cancer Research, 2011
- Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumoursBritish Journal of Cancer, 2011
- Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial CancerCancer Research, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerThe New England Journal of Medicine, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphomaThe EMBO Journal, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006